Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157
Tel: +81 (0)80-1164-4754
Request a Demo
What our customers are saying
When I think of the future, I think of EvaluatePharma
Global pharmaceutical company
EvaluatePharma Orphan Drug 2017 Report
Worldwide orphan drug sales forecast to total $209bn
The steady and inexorable growth of the orphan drug market remains one of the prominent themes in the fourth edition of the EvaluatePharma Orphan Drug Report 2017.
What has changed in the last 12 months according to the report is the increased scrutiny of the price of these lifesaving products.
- Worldwide orphan drug sales forecast to total $209bn (CAGR 2017 to 2022:+11.1%); approximately double overall prescription market growth
- Orphan drugs set to be 21.4% of worldwide prescription sales by 2022 (excluding generics)
- Median cost per patient differential 5.5 times higher for orphan drugs compared to non-orphan
View Orphan Drug 2017 Infographic
Confirm your details on form below to download this report